United States · FDA National Drug Code directory

Doxylamine succinate and pyridoxine hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0591-2132_a51f5dfd-c4ff-4fea-8a7c-1fc058cd7c11
Product NDC: 0591-2132
Form: TABLET, DELAYED RELEASE
Composition / generic term: Doxylamine succinate and pyridoxine hydrochloride
Labeler: Actavis Pharma, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20190621
Source listing expiry: 20261231

Source-listed ingredients

DOXYLAMINE SUCCINATE — 10 mg/1
PYRIDOXINE HYDROCHLORIDE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-2132-01) · 0591-2132-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →